1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY

✍ Scribed by Llovet, J.M.; Decaens, T.; Raoul, J.-L.; Boucher, E.; Kudo, M.; Chang, C.; Kang, Y.-K.; Assenat, E.; Lim, H.-Y.; Boige, V.; Mathurin, P.; Fartoux, L.; Lin, D.-Y.; Bruix, J.; Poon, R.T.; Sherman, M.; Blanc, J.-F.; Finn, R.; Tak, W.-Y.; Chao, Y.; Ezzeddine, R.; Liu, D.; Walters, I.; Park, J.-W.

• Book ID: 122428455
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 159 KB
• Volume: 56
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(12)61409-3